TFF Pharmaceuticals Inc. and Uniphar Durbin Ireland Ltd. Announce the Opening of an Expanded Access Program for Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Pulmonary Aspergillosis and Other Voriconazole Responsive Fungal Pulmonary Infections

By
Jamie Kang
-
0
134
Uniphar Durbin Ireland, Ltd. and TFF Pharmaceuticals, Inc. announced the opening of an Expanded Access Program enabling patients access to TFF-VORI in the United States, Australia, United Kingdom, Canada, and select countries in Europe.
[TFF Pharmaceuticals, Inc.]
Press Release